baber/WOPTO huggingface dataset:
Patent DE-69100094-D1 (DE)
Inventor: GOERING STEFAN DR
IPC: A61K8/30
Filed: 1991-12-11
Granted: 1993-07-01
Abstract: This invention refers to cosmetic compositions, particularly a skin treating preparation, comprising a transparent oil phase and a transparent aqueous phase, preferably with humectant effect, which permits a homogeneous mixture when being shaken, and which separates again in two transparent phases thereafter. These properties are achieved by the addition of 0.1 to 1.0% by weight of a C12-C18 fatty acid triglycerol ester.
Patent DE-69104374-D1 (DE)
Inventor: HOYOS MARC
IPC: D21C9/16
Filed: 1991-10-04
Granted: 1994-11-03
Abstract: PCT No. PCT/EP91/01906 Sec. 371 Date Apr. 15, 1993 Sec. 102(e) Date Apr. 15, 1993 PCT Filed Oct. 4, 1991 PCT Pub. No. WO92/07139 PCT Pub. Date Apr. 30, 1992.Process for preserving the mechanical strength properties of a chemical paper pulp, comprising two treatment stages by means of a peroxidic reagent, with the first stage in an acidic medium and the second stage in an alkaline medium, according to which a treatment by means of a reducing compound is interposed between the two stages.
Patent DE-69123346-D1 (DE)
Inventor: BAKER GERALD S
IPC: F16K31/46
Filed: 1991-08-30
Granted: 1997-01-09
Abstract: A manual operator which is useful when used with a valve or other type of device to provide either manual operation of the valve in one direction or to provide a stop against the movement of the valve away from one of its extreme positions. The device includes a ball nut (60), screw shaft (62) and balls (64) positioned in facing grooves in the nut and shaft so that relative rotation has very low friction. Thus rotation of one of the nut or screw shaft results in axial movement of the screw shaft (62) so that it can move or provide a stop. Aligned adjacent exterior surfaces are provided on a rotating part of the device and one a stationary part of the device which surfaces are engaged by a locking spring (76) which can be release from such surfaces when it is desired that the manual operator cause an axial movement of screw shaft (62). In one form of the invention the screw shaft rotates and the ball nut is stationery. In another form the ball nut rotates and the screw shaft is stationary. In a third form two locking springs are provided to lock against inadvertent relative rotation in both directions. In still another form of the apparatus, it is applied to a blowout preventer ram tail rod so that the axial movement of the tail rod is translated into rotation of a ball nut and a spring engages a surface rotating with the ball nut and a stationary aligned surface to prevent relative rotation in one direction to lock the tail rod with the piston in its inner or ram closed position.
Patent DE-69123665-D1 (DE)
Inventor: GEPHARDT DOUGLAS D
IPC: H01L21/822
Filed: 1991-07-23
Granted: 1997-01-30
Abstract: An integrated digital processing apparatus (10) for use in a computing device. The apparatus comprises a central processor (14) for effecting processing functions according to a program, a plurality of bus-accommodating devices (18,26,34) for accommodating direct operative connection of peripheral devices via a plurality of buses (16,24,32), a single internal bus (80) for accommodating communications internal of the apparatus among the central processing unit and the plurality of bus-accommodating devices, and an internal bus control (90) for controlling utilization of the internal bus. The apparatus is, preferably, configured as an integrated digital circuit on a single substrate. <IMAGE>
Patent DE-69200242-D1 (DE)
Inventor: KUZNITZ MATTHEW
IPC: A61K8/30
Filed: 1992-01-28
Granted: 1994-08-25
Abstract: A clear gel composition is provided which includes a polyhydric alcohol, a soap, an alkoxylate copolymer and a fragrance. For purposes of maintaining clarity, the fragrance will contain at most 25% of total ester compounds by weight of the fragrance.
Patent DE-69203764-D1 (DE)
Inventor: FAESI ROLAND
IPC: A23J3/32
Filed: 1992-03-07
Granted: 1995-09-07
Abstract: The chlorohydrin content of a liquid containing hydrolysed protein obtained by hydrolysis of protein with hydrochloric acid is reduced in an apparatus system by introducing alkali into the liquid flowing under pressure in a piping system to increase the pH of the liquid, after which the pH-increased flowing liquid is heated, and then the heated flowing liquid is held for a time sufficient in a holding piping section to reduce the chlorohydrin content of the hydrolysed protein contained in the liquid. The flowing liquid under pressure then is cooled before or after addition of hydrochloric acid which is employed to adjust the pH of the liquid. <IMAGE>
Patent DE-69206470-D1 (DE)
Inventor: RAPAILLE ANDRE LEON IVON
IPC: A23L27/30
Filed: 1992-04-16
Granted: 1996-01-18
Abstract: A composition which is suitable as the sweetener base of a sweet, reduced calorie food product such as an instant pie filling or a bakery cream, comprises erythritol, sorbitol and a glucose oligomer having DE of 10 to 30, particularly 20 to 23. The composition may also contain fructose and/or maltitol or an intense sweetener such as aspartame.
Patent DE-69209990-D1 (DE)
Inventor: SLUTZ DAVID EARL
IPC: C23C16/01
Filed: 1992-12-01
Granted: 1996-05-23
Abstract: In a chemical vapor deposition method for producing a diamond film substantially free of thermal stress-induced cracks, diamond growth occurs on both sides of a thin substrate so that two diamond coatings with identical opposing tensile forces are formed on each side of the substrate at a thickness greater than the thickness of the substrate.
Patent DE-69212123-D1 (DE)
Inventor: GALAJ STANISLAS
IPC: C08G73/00
Filed: 1992-12-03
Granted: 1996-08-14
Abstract: Copolymers with magnetic properties containing aminoaromatic groups, based on an elementary unit comprising:   - a first group of aminoaromatic compounds chosen from aniline derivatives and the corresponding iminoquinonic forms, - a second group of substituted aminoaromatic compounds chosen from substituted amino compounds containing at least two condensed benzene nuclei, substituted polycyclic compounds containing at least one aniline unit in their structure, compounds derived from aniline carrying a substituent linked to the nucleus via an ethynylidene or para-phenylene link, and the corresponding iminoquinonic compounds. s
Patent DE-69220770-D1 (DE)
Inventor: OLSEN ROBB
IPC: A61F13/511
Filed: 1992-07-23
Granted: 1997-08-14
Abstract: A napkin comprises an absorbent core between a pervious topsheet and an impervious backsheet, with all parts extensible, and a fastener for securing the napkin to the garment, the fastener allowing at least parts of the napkin to extend. The napkin is pref. extensible both longitudinally and transversely and may require extending before applying to the garment, or may be extended by forces applied during use. Stretched length is pref. at least 25% greater than unstretched length. The napkin may be provided with a pull-out tab so that the user can lengthen the napkin.
Patent DE-69222211-D1 (DE)
Inventor: CIRRI GIANFRANCO
IPC: H01J27/18
Filed: 1992-02-28
Granted: 1997-10-23
Abstract: An ion engine comprising means for the generation of primary plasma by discharge in a gas wherein said discharge is obtained by means of the simultaneous use of a magnetic conditioning and confinement field and an electromagnetic field, the latter being at a frequency such that the cyclotron resonance effect of the electrons in the gas can be exploited. The engine comprises means (5, 7) of generating a static magnetic field and means (9, 11) of generating and applying an electromagnetic field at cyclotron frequency. By using the cyclotron resonance effect, it is possible to improve the processes of plasma generation and the processes of ion beam extraction by means of the use of an optimized system of grids made of refractory material. These processes are optimized to match the differences in the operating conditions acting on the intensity of the magnetic field. <IMAGE>
Patent DE-69222500-D1 (DE)
Inventor: SPICER DARCY
IPC: A61K9/16
Filed: 1992-04-10
Granted: 1997-11-06
Abstract: PCT No. PCT/US92/02973 Sec. 371 Date Feb. 1, 1993 Sec. 102(e) Date Feb. 1, 1993 PCT Filed Apr. 10, 1992.Compositions and methods which are effective to inhibit conception and to treat benign gynecological disorders for extended periods of time are described, wherein an effective amount of a gonadotropin hormone releasing hormone composition and an effective amount of an estrogenic composition are provided over a first period of time, in addition to a progestogen and optionally an androgenic composition. According to one protocol, the progestogen is provided for a second, shorter period of time; the progestogen is provided at a higher level for at least 5 to about 20 days, and then at a lower level for the remainder, if any, of the second period of time. In an alternative protocol, the progestogen is provided at a lower level substantially throughout the period of administration of gonadotropin hormone releasing hormone composition and estrogenic composition. An effective amount of the androgenic hormone is optionally provided over the first period of time.
Patent DE-69230306-D1 (DE)
Inventor: FARRAND SCOTT C
IPC: G06F1/24
Filed: 1992-09-07
Granted: 1999-12-23
Abstract: A computer system remote reboot facility is provided by resetting the central processing unit (108) with a local or host console (106) and by effecting a bus reset, by signals from a remote console (34) transmitted over an asynchronous line (104) connecting the remote console to the computer system manager (22) within the host (106). The computer system manager (22), preferably together with a keyboard controller (110), generate the reset signals. Effectively, cold booting is effected by the remote console simulating the effect of power cycling on the host and warm booting is achieved by emulation of "CONTROL-ALT-DEL" keystrokes. <IMAGE>
Patent DE-69314186-D1 (DE)
Inventor: BRU-MAGNIEZ NICOLE
IPC: A61K47/22
Filed: 1993-12-09
Granted: 1997-10-30
Abstract: The present invention relates to a novel pharmaceutical composition for the preparation of effervescent powders or tablets incorporating ibuprofen or one of its pharmaceutically acceptable salts as the active ingredient. This composition comprises: an effective amount of ibuprofen or one of its pharmaceutically acceptable salts; a pharmaceutically acceptable effervescent system comprising at least one alkaline carbonate and at least one organic acid, preferably in a sufficient amount to give a pH below about 8; and at least one pharmaceutically acceptable antioxidant in a sufficient amount to stabilize the ibuprofen. This composition has a remarkable stability both in powder form and in tablet form.
Patent DE-69329284-D1 (DE)
Inventor: CZAPSKI J
IPC: A47D11/02
Filed: 1993-05-04
Granted: 2000-09-28
Abstract: A child seat module integrated with a rear vehicle seat, and including fold-down lower and upper segments, interconnected by a flexible and detachable hinge, and a plastic back panel mounted against the back frame of the bench seat. A plastic seat pad support platform is mounted on the inner surface of the lower segment. A pad having seat and back segments is removably mounted on the platform and against the back panel. A safety belt system is operably included in the module. The interconnected lower and upper segments are adapted to being folded down to form, with the platform and pad, a child seat cushion and leg support. Alternatively, the leg support may be removed for a child whose size is such that use of the leg support would be uncomfortable.
Patent DE-69329651-D1 (DE)
Inventor: O'CONNOR H
IPC: A61K47/26
Filed: 1993-07-29
Granted: 2000-12-14
Abstract: A stable pharmaceutically acceptable aqueous formulation containing human growth hormone, a buffer, a non-ionic surfactant, and, optionally, a neutral salt, mannitol, or, a preservative, is disclosed. Also disclosed are associated means and methods for preparing, storing, and using such formulations.
Patent DE-69413167-D1 (DE)
Inventor: DOLLE ROLAND E
IPC: C07F9/48
Filed: 1994-06-02
Granted: 1998-10-15
Abstract: Disclosed are compounds, compositions and methods for inhibiting interleukin - 1 beta  protease activity, the compounds having the formula (I) disclosed herein.
Patent DE-69418343-D1 (DE)
Inventor: BUJAC PAUL DAVID BERNARD
IPC: C07C17/16
Filed: 1994-12-14
Granted: 1999-06-10
Abstract: A process for the production of difluoromethane which comprises contacting bis(fluoromethyl)ether in the liquid phase with boron trifluoride under conditions such that the molar ratio of boron trifluoride to bis(fluoromethyl) ether is at least 0.5:1.
Patent DE-69428455-D1 (DE)
Inventor: GREAVES FRANK C
IPC: A61K9/20
Filed: 1994-12-20
Granted: 2001-10-31
Abstract: Disclosed is a wet method for preparing solid pharmaceutical composition for oral administration of low-dose medications whose active ingredients have steroidal or steroid-like structures. The meethod suspends medicaments with low solubility in an aqueous binder solution with a trace amount of surfactant. The aqueous suspension is then blended with fillers and granulated. The dried granules can be made into capsules, tablets, lozenges, troches, sustained or delayed release products or suspensions.
Patent DE-69430503-D1 (DE)
Inventor: SUPPLEE WILLIAM W
IPC: C09D5/44
Filed: 1994-02-08
Granted: 2002-06-06
Abstract: This invention relates to modifying the surface of particles for improved dispersion characteristics in aqueous, solvent, resinous, polymeric, cementitious or the like application systems. In particular, this invention relates to a pigment or filler particle whose surface is coated with at least one electric charge modifying agent and at least one dispersion promoting agent, which has improved dispersibility, coloring, handling, and other processing properties in application systems. The electric charge modifying agent may be selected from the group of Mg, Ca, Ba, Sr, Ti, V, Zr, Cr, Mn, Fe, Co, Ni, Cu, Zn, and Al. The dispersion promoting agent may be selected from the group of stearates, acetates, alkylphenols, cellulosics, waxes, lignins, polyacrylics, polyepoxies, polyurethanes, polyethylenes, polystyrenes and polypropylenes, and polymers having functional groups of alcohols, glycols, aldehydes, amides and carboxylic acids. Iron oxide is the preferred pigment particle.
Patent DE-69431100-D1 (DE)
Inventor: ZACHARIADES ANAGNOSTIS E
IPC: A61C15/04
Filed: 1994-12-20
Granted: 2002-09-05
Abstract: Thermoplastic tape, ribbon or line material is prepd. as follows: (a) a melt-crystallised precursor polyethylene tape (I) of mol. wt. above 300,000 is immersed in a liq. bath at ca. 130 [deg]C until it has swelled into a pseudo-gel state; (b) the swollen tape is compressed lightly then treated with a solvent to remove all residual bath liq.; (c) the tape is heated to remove all residual solvent and provide a dried porous prod. with higher porosity than the original (I); (d) the prod. is compressed at 100,300,000 psi (depending on the thickness), and (e) the tape is stretched at 80-130 [deg]C to afford a drawn prod. with increased mechanical props. including a modulus 0.5-100 GPa, and tensile strength 0.1-2 GPa.
Patent DE-69431114-D1 (DE)
Inventor: LADD ANNA E
IPC: C07K14/12
Filed: 1994-04-28
Granted: 2002-09-05
Abstract: This invention relates to immunogenic luteinizing hormone releasing hormone (LHRH) peptides that lead to suppression of LHRH activity in males or females. When male rats are immunized with these peptides, serum testosterone drops and androgen-dependent organs atrophy significantly. These peptides are useful for inducing infertility and for treating prostatic hyperplasia, androgen-dependent carcinoma, prostatic carcinoma and testicular carcinoma in males. In females, the peptides are useful for treating endometriosis, benign uterine tumors, recurrent functional ovarian cysts and (severe) premenstrual syndrome as well as prevention or treatment of estrogen-dependent breast cancer. The subject peptides contain a helper T cell epitope and have LHRH at the C terminus. The helper T cell epitope aids in stimulating the immune response against LHRH. The peptides, optionally contain an invasin domain which acts as a general immune stimulator. In another aspect this invention relates to immunogenic synthetic peptides having an invasin domain, a helper T cell epitope and a peptide hapten and methods of using these peptides to treat disease or provide protective immunity. The peptide haptens of the invention include LHRH, amylin, gastrin, gastrin releasing peptide, IgE CH4 peptide, Chlamydia MOMP peptides, HIV V3 peptides and Plasmodium berghei.
Patent DE-69435307-D1 (DE)
Inventor: LAMBERT BART
IPC: A01N63/00
Filed: 1994-02-25
Granted: 2010-09-16
Abstract: The present invention relates to transformed microrganisms comprising DNA molecules encoding Bacillus thuringiensis proteins with insecticidal activity. The invention relates more particularly to transformed microrganisms comprising DNA molecules encoding the protease resistant toxins BTS02618Aa or BTS02618Ab.
Patent DE-69511422-D1 (DE)
Inventor: HOFMANN GUNTER
IPC: A61K35/18
Filed: 1995-10-12
Granted: 1999-09-16
Abstract: A flow through apparatus for implanting molecules into living blood cells of a patient, comprises a housing including an elongated flow through chamber having an inlet and an outlet at opposite ends thereof, a pair of elongated spaced apart parallel electrodes disposed between the inlet and the outlet for fluid to flow therebetween, a continuous flow shunt including a pump for withdrawing blood from a patient, passing it through the flow through chamber between the electrodes and returning it to the patient, apparatus for injecting a predetermined quantity of fluid medium carrying preselected molecules into the blood after it has been drawn from the patient and before it passes through said chamber, and an electrical source for applying a predetermined electric signal of a predetermined amplitude and duration to the electrodes for generating and repeatedly applying electric fields of a predetermined amplitude and duration to the flow of the mixture of blood and fluid medium in order to make the walls of preselected cells in the blood transiently permeable to permit molecules to enter the preselected cells without killing the cells.
Patent DE-69524388-D1 (DE)
Inventor: ARTIS R
IPC: C07D407/06
Filed: 1995-02-16
Granted: 2002-01-17
Abstract: The disclosed derivatives of mycophenolic acid are therapeutic agents advantageous in the treatment of disease states indicated for mycophenolic acid and/or mycophenolate mofetil and other immunosuppressant agents.
Patent DE-69603152-D1 (DE)
Inventor: NOBLE PHILIPPE
IPC: C08F236/06
Filed: 1996-09-19
Granted: 1999-08-12
Abstract: A long-life polymeric packaging containing a fruit and/or vegetable beverage, and consisting of a single layer of methyl acrylate-acrylonitrile-butadiene terpolymer, is disclosed. A method for controlling the spoilage of fruit and/or vegetable beverages in a polymeric packaging, characterised in that said packaging consists of a single layer of methyl acrylate-acrylonitrile-butadiene terpolymer, is also disclosed.
Patent DE-69605661-D1 (DE)
Inventor: BERGER ABE
IPC: A61Q5/02
Filed: 1996-04-11
Granted: 2000-01-20
Abstract: A polysiloxane composition is provided having the formula   <IMAGE>   wherein: R1, can be R2 or at least one pyrrolidone containing group of the general formula:   <IMAGE>    wherein; R5 is hydrogen, lower alkyl or alkali metal; F, is linear or branched alkylene of 1-12 carbon atoms; n is 0 or 2; n1 is 0 or 1; n2 is 0 or 1; and B is -NR9, sulfur or oxygen, wherein R, is hydrogen or lower alkyl; with the proviso that when n is 0 and n2 is 1, n1 is 1, when n is 2 and n2 is 1, n1 is 0 or 1 and when n is 2 and n2 is 0, n1 is 0; R2 is selected from alkyl, aryl and olefinic (vinyl); R3 and R4, are selected from alkyl, aryl, capped or uncapped polyoxyalkylene, alkaryl, aralkylene or alkenyl; a is an integer from 0 to 50,000; and b is an integer from 0 to 100.
Patent DE-69609949-D1 (DE)
Inventor: NORDSTROEM GUNNAR
IPC: B65G65/00
Filed: 1996-02-13
Granted: 2000-09-28
Abstract: PCT No. PCT/SE96/00179 Sec. 371 Date Aug. 4, 1997 Sec. 102(e) Date Aug. 4, 1997 PCT Filed Feb. 13, 1996 PCT Pub. No. WO96/25351 PCT Pub. Date Aug. 22, 1996The present invention relates to an apparatus for feeding solid fuels in a space limited by a plane bottom plate, side walls and a pusher device arranged adjacent the bottom surface. A drive is located outside the walls and is attached to the pusher in order to obtain a reciprocating movement of the pusher. The invention is characterized in that the pusher comprises a number of pusher rods arranged substantially parallel with each other and substantially parallel with the bottom surface.
Patent DE-69616741-D1 (DE)
Inventor: KANEKO AKIHITO
IPC: H01M4/24
Filed: 1996-08-28
Granted: 2001-12-13
Abstract: A rare earth metal/nickel-base hydrogen absorbing alloy having a composition represented by formula (1): (R1-x Lx )(Ni1-y My )z , (wherein R represents La, Ce, Pr, or Nd; L represents Gd, Tb, Dy, Ho, Er, Tm, Yb, Lu, Y, Sc, Mg, or Ca; and M represents Co, Al, Mn, Fe, Cu, Zr, Ti, Mo, Si, V, Cr, Nb, Hf, Ta, W, B, or C; 0,01 ≤ x ≤ 0.1; 0 ≤ y ≤ 0.5; and 4.5 ≤ z ≤ 5.0), wherein the content of crystals with the number of reversed-phase boundaries present perpendicularly to the C axis of crystal grains in the alloy being 2 to less than 20 per 20 nm in the direction of the C axis is 10 to less than 95 vol.% and the amount of L in the formula (I) present in the reversed-phase region is 60 to less than 95 % of the amount of L added. The negative electrode for the nickel-hydrogen secondary battery can simultnaneously improve all of the initial activity, battery capacity, and battery life.
Patent DE-69636013-D1 (DE)
Inventor: FITZPATRICK JUDITH
IPC: G01N33/543
Filed: 1996-06-19
Granted: 2006-05-18
Abstract: Assays using receptor:reland complexes capable of releasing the reland in the presence of an analyte are described, wherein the reland does not detectably compete with analyte for binding to the receptor. The dissociation constant of the reland and the receptor is such that no appreciable release of reland occurs in the absence of analyte for the receptor. In a preferred embodiment, the association constant of the monomeric reland and the receptor is less than or equal to about 105M, preferably 103 to 105M, most preferably 1% or less of the association constant of the analyte and receptor. In a preferred embodiment, the reland is labelled and the amount of analyte bound to the receptor is determined from the amount of labelled reland which is released.
Patent DE-69637424-D1 (DE)
Inventor: MAYER BRUNO FRANZ
IPC: A61M39/04
Filed: 1996-04-18
Granted: 2008-03-20
Abstract: A needleless injection site comprising a housing which defines an interior chamber and a central opening which communicates with the interior chamber. The housing further defines a proximally extending dilator projection portion which is co-axially aligned with the central opening and a distally extending adapter portion. The dilator projection and adapter portions define a continuous fluid passage. Disposed within the central opening and the interior chamber is a reseal member which has an elastically openable and closable aperture formed therein. The reseal member normally resides in a first position within the housing wherein the aperture is in a closed configuration. The reseal member is deformable such that the application of distally directed pressure thereto will cause the reseal member to distally advance within the housing to a second position wherein the aperture assumes an open configuration and communicates with the fluid passage. The cessation of the application of distally directed pressure to the reseal member will cause it to resiliently return to the first position wherein the aperture reassumes the closed configuration.